Subcutaneous MabThera (Rituxan) approved for ... - CLL Support
Subcutaneous MabThera (Rituxan) approved for NHL, CLL should follow... New formulation cuts treatment time to five minutes.
You need to be a member of this community to see this post.
5 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Venetoclax plus Rituximab
Hi, I'm new to this forum and am wondering if anyone knows of any trials
of Venetoclax plus...
B cell lymphoma lumps
I was just reviewing a post about a P cell lymphoma that someone had in there neck or upper lower...
ATTENTION CLL + SLL PATIENTS AND CAREGIVERS
Lymphoma Canada and the CLL Patient Advocacy Group (CLLPAG) is preparing a submission for the...
Novel Bruton’s Tyrosine Kinase (BTK) inhibitor, ONO-4059 enters UK CLL clinical trial
A new BTK inhibitor enters the fray in Chronic Lymphocytic Leukaemia and Small Lymphocytic...
Canadian Study...treatment increases risk of secondary cancers in CLL
Treated CLL patients had a 1.7-fold increased risk of second cancers compared with untreated CLL...
Top 10 list of what we need to know about lymphoma
Venetoclax(ABT-199)/rituximab achieved an Overall Rate of Response of 88%
Rituximab, gets cheaper.
Ibrutinib stopped working, what’s next
